NEA Management Company, LLC - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 118 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$69,085,279
+22.1%
2,186,2430.0%5.34%
+23.6%
Q2 2023$56,558,106
-43.8%
2,186,243
-47.8%
4.32%
-37.9%
Q1 2023$100,553,557
+23.2%
4,186,2430.0%6.95%
+51.5%
Q4 2022$81,631,739
-7.2%
4,186,243
-0.0%
4.59%
+4.4%
Q3 2022$87,986,000
+8.0%
4,187,8010.0%4.39%
+4.9%
Q2 2022$81,495,000
-11.6%
4,187,8010.0%4.19%
+57.1%
Q1 2022$92,215,000
+38.1%
4,187,8010.0%2.66%
+97.3%
Q4 2021$66,795,000
-19.9%
4,187,8010.0%1.35%
+36.2%
Q3 2021$83,421,000
+15.2%
4,187,8010.0%0.99%
+5.1%
Q2 2021$72,407,000
-12.8%
4,187,8010.0%0.94%
-49.4%
Q1 2021$83,002,000
+13.5%
4,187,8010.0%1.86%
-3.5%
Q4 2020$73,119,000
-9.4%
4,187,8010.0%1.93%
-43.5%
Q3 2020$80,699,000
-1.0%
4,187,8010.0%3.42%
+4.3%
Q2 2020$81,495,000
+39.0%
4,187,8010.0%3.28%
+7.0%
Q1 2020$58,629,000
-42.9%
4,187,8010.0%3.06%
-36.9%
Q4 2019$102,685,000
+143.7%
4,187,8010.0%4.86%
+39.2%
Q3 2019$42,129,0004,187,8013.49%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 6,470,392$204,464,38713.58%
NEA Management Company, LLC 2,186,243$69,085,2795.34%
TANG CAPITAL MANAGEMENT LLC 1,137,107$35,932,5815.07%
BOONE CAPITAL MANAGEMENT LLC 389,791$12,317,3963.89%
Highlander Partners, L.P. 122,980$3,886,1683.84%
BVF INC/IL 4,370,024$138,092,7583.72%
Prosight Management, LP 353,508$11,170,8533.54%
Novo Holdings A/S 1,500,000$47,400,0003.50%
Nicholas Investment Partners, LP 1,199,366$37,899,9662.83%
Eventide Asset Management 3,958,579$125,091,0972.25%
View complete list of MIRUM PHARMACEUTICALS INC shareholders